Cargando…
Tissue plasminogen activator-assisted vitrectomy for submacular hemorrhage due to age-related macular degeneration
PURPOSE: The purpose of this study was to evaluate the treatment efficacy of vitrectomy combined with subretinal recombinant tissue plasminogen activator (r-tPA) and factors affecting visual improvement in patients with submacular hemorrhage (SMH) due to neovascular age-related macular degeneration...
Autores principales: | Gök, Mustafa, Karabaş, V Levent, Aslan, Mehmet Ş, Kara, Özgür, Karaman, Süleyman, Yenihayat, Fatih |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5508459/ https://www.ncbi.nlm.nih.gov/pubmed/28643713 http://dx.doi.org/10.4103/ijo.IJO_129_16 |
Ejemplares similares
-
Subretinal tissue plasminogen-assisted vitrectomy for posttraumatic full-thickness macular hole with submacular hemorrhage
por: Kumar, Pradeep, et al.
Publicado: (2018) -
Displacement of submacular hemorrhage associated with age-related macular degeneration using vitrectomy and submacular tPA injection followed by intravitreal ranibizumab
por: Sandhu, Sukhpal Singh, et al.
Publicado: (2010) -
Long-Term Outcome of Eyes with Vitrectomy for Submacular and/or Vitreous Hemorrhage in Neovascular Age-Related Macular Degeneration
por: Kawakami, Setsuko, et al.
Publicado: (2021) -
Displacement of submacular hemorrhage secondary to age-related macular degeneration with subretinal injection of air and tissue plasminogen activator
por: Ogata, Maasa, et al.
Publicado: (2022) -
Submacular hemorrhage secondary to age-related macular degeneration managed with vitrectomy, subretinal injection of tissue plasminogen activator, hemorrhage displacement with liquid perfluorocarbon, gas tamponade, and face-down positioning()
por: Ozkaya, Abdullah, et al.
Publicado: (2018)